Literature DB >> 20720138

Obesity, age, sex, diagnosis, and fixation mode differently affect early cup failure in total hip arthroplasty: a matched case-control study of 4420 patients.

Christoph Röder1, Belinda Bach, Daniel J Berry, Stefan Eggli, Ronny Langenhahn, Andre Busato.   

Abstract

BACKGROUND: Studies about the influence of patient characteristics on mechanical failure of cups in total hip replacement have applied different methodologies and revealed inconclusive results. The fixation mode has rarely been investigated. Therefore, we conducted a detailed analysis of the influence of patient characteristics and fixation mode on cup failure risks.
METHODS: We conducted a case-control study of total hip arthroplasties in 4420 patients to test our hypothesis that patient characteristics of sex, age, weight, body mass index, and diagnosis have different influences on risks for early mechanical failure in cemented and uncemented cups.
RESULTS: Women had significantly reduced odds for failure of cups with cemented fixation (odds ratio = 0.59; 95% confidence interval, 0.43 to 0.83; p = 0.002) and uncemented fixation (odds ratio = 0.63; 95% confidence interval, 0.5 to 0.81; p = 0.0003) compared with that for men (odds ratio = 1). Each additional year of patient age at the time of surgery reduced the failure odds by a factor of 0.98 for both cemented cups (odds ratio = 0.98; 95% confidence interval, 0.96 to 0.99; p = 0.016) and uncemented cups (odds ratio = 0.98; 95% confidence interval, 0.97 to 0.99; p = 0.0002). In patients with cemented cups, the weight group of 73 to 82 kg had significantly lower failure odds (odds ratio = 0.63; 95% confidence interval, 0.4 to 0.98) than the lightest (<64 kg) weight group or the heaviest (>82 kg) weight group (odds ratios = 1.00 and 1.07, respectively). No significant effects of weight were noted in the uncemented group. In contrast, obese patients (a body mass index of >30 kg/m(2)) with uncemented cups had significantly elevated odds relative to patients with a body mass of <25 kg/m(2) (odds ratio = 1.41; 95% confidence interval, 1.03 to 1.91) for early failure of the cups compared with an insignificant effect in the cemented arm of the study. Compared with osteoarthritis as the reference diagnosis (odds ratio = 1), developmental dysplasia (odds ratio = 0.52; 95% confidence interval, 0.28 to 0.97) and hip fracture (odds ratio = 0.38; 95% confidence interval, 0.16 to 0.92) were significantly protective in cemented cups.
CONCLUSIONS: Female sex and older age have similarly protective effects on the odds for early failure of cemented and uncemented cups. Although a certain body-weight range has a significant protective effect in cemented cups, the more important finding was the significantly increased risk for failure of uncemented cups in obese patients. Patients with developmental dysplasia and hip fracture were the only diagnostic groups with a significantly decreased risk for cup failure, but only with cemented fixation. LEVEL OF EVIDENCE: Therapeutic Level III. See Instructions to Authors for a complete description of levels of evidence.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20720138     DOI: 10.2106/JBJS.F.01184

Source DB:  PubMed          Journal:  J Bone Joint Surg Am        ISSN: 0021-9355            Impact factor:   5.284


  11 in total

1.  Clinical Factors, Disease Parameters, and Molecular Therapies Affecting Osseointegration of Orthopedic Implants.

Authors:  Hilal Maradit Kremers; Eric A Lewallen; Andre J van Wijnen; David G Lewallen
Journal:  Curr Mol Biol Rep       Date:  2016-06-29

2.  [Utilization rates of lower extremity prostheses in Germany and Switzerland: A comparison of the years 2005-2008].

Authors:  I Falbrede; M Widmer; S Kurtz; D Schneidmüller; M Dudda; C Röder
Journal:  Orthopade       Date:  2011-09       Impact factor: 1.087

3.  Safety, effectiveness and predictors for early reoperation in therapeutic and prophylactic vertebroplasty: short-term results of a prospective case series of patients with osteoporotic vertebral fractures.

Authors:  Peter Diel; Lorenz Freiburghaus; Christoph Röder; Lorin Michael Benneker; Albrecht Popp; Gosia Perler; Paul Ferdinand Heini
Journal:  Eur Spine J       Date:  2011-08-30       Impact factor: 3.134

4.  Clinically important body weight gain following total hip arthroplasty: a cohort study with 5-year follow-up.

Authors:  D L Riddle; J A Singh; W S Harmsen; C D Schleck; D G Lewallen
Journal:  Osteoarthritis Cartilage       Date:  2012-10-06       Impact factor: 6.576

5.  Obesity increases length of stay and direct medical costs in total hip arthroplasty.

Authors:  Hilal Maradit Kremers; Sue L Visscher; Walter K Kremers; James M Naessens; David G Lewallen
Journal:  Clin Orthop Relat Res       Date:  2013-10-08       Impact factor: 4.176

6.  Aseptic Loosening after THA and TKA - Do gender, tobacco use and BMI have an impact on implant survival time?

Authors:  Erik Schiffner; David Latz; Simon Thelen; Jan P Grassmann; Alfred Karbowski; Joachim Windolf; Pascal Jungbluth; Johannes Schneppendahl
Journal:  J Orthop       Date:  2019-04-08

7.  CoCrMo alloy vs. UHMWPE Particulate Implant Debris Induces Sex Dependent Aseptic Osteolysis Responses In Vivo using a Murine Model.

Authors:  Stefan Landgraeber; Lauryn Samelko; Kyron McAllister; Sebastian Putz; Joshua J Jacobs; Nadim James Hallab
Journal:  Open Orthop J       Date:  2018-03-30

Review 8.  Factors Affecting Periprosthetic Bone Loss after Hip Arthroplasty.

Authors:  Se-Won Lee; Weon-Yoo Kim; Joo-Hyoun Song; Jae-Hoon Kim; Hwan-Hee Lee
Journal:  Hip Pelvis       Date:  2021-06-04

9.  Cemented versus uncemented fixation in total hip replacement: a systematic review and meta-analysis of randomized controlled trials.

Authors:  Ali Abdulkarim; Prasad Ellanti; Nicola Motterlini; Tom Fahey; John M O'Byrne
Journal:  Orthop Rev (Pavia)       Date:  2013-03-15

10.  Matched case-control studies: a review of reported statistical methodology.

Authors:  Daniel J Niven; Luc R Berthiaume; Gordon H Fick; Kevin B Laupland
Journal:  Clin Epidemiol       Date:  2012-04-27       Impact factor: 4.790

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.